NHI (NYSE: NHI) CIO exercises options and disposes 13,602 common shares

Rhea-AI Filing Summary

National Health Investors Inc.'s Chief Investment Officer, Kevin C. Pascoe, reported multiple equity transactions in the company’s common stock. On January 30, 2026, he exercised two stock option awards for 8,500 shares each at exercise prices of $54.73 and $57.76, increasing his directly held common shares to 78,330.

On the same date, he reported a disposition coded "F" of 13,602 common shares at $82.12 per share. After these transactions, Pascoe directly beneficially owned 64,728 shares of National Health Investors common stock.

Insider Trade Summary

Net Buyer: 3,398 shares

Net Buy 5 txns

Insider PASCOE KEVIN CARLTON

Role Chief Investment Officer

Type	Security	Shares	Price	Value
Exercise	Stock Option (Right to Buy) 2023	8,500	$0.00	$0.00
Exercise	Stock Option (Right to Buy) 2024	8,500	$0.00	$0.00
Exercise	Common Stock	8,500	$54.73	$465K
Exercise	Common Stock	8,500	$57.76	$491K
Exercise Price or Tax Liability	Common Stock	13,602	$82.12	$1.12M

Holdings After Transaction: Stock Option (Right to Buy) 2023 — 0 shares (Direct); Stock Option (Right to Buy) 2024 — 0 shares (Direct); Common Stock — 64,728 shares (Direct)

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 02/03/2026 - 05:00 PM Learn about SEC filing dates

FAQ

What insider transaction did NHI Chief Investment Officer report?

Kevin C. Pascoe reported exercising stock options and disposing of shares. On January 30, 2026, he exercised two option grants for 17,000 common shares total and reported a disposition of 13,602 common shares, adjusting his directly owned stake in National Health Investors.

How many NHI stock options did Kevin C. Pascoe exercise?

He exercised options for 17,000 NHI common shares in total. The Form 4 shows two stock option exercises, each covering 8,500 shares, with exercise prices of $54.73 and $57.76, both dated January 30, 2026, increasing his common stock holdings before the subsequent disposition.

At what prices were the NHI stock options exercised by the CIO?

The options were exercised at $54.73 and $57.76 per share. One 2023 stock option grant covered 8,500 shares at $54.73, and a 2024 grant covered another 8,500 shares at $57.76, both converted into National Health Investors common stock on January 30, 2026.

How many NHI shares did Kevin C. Pascoe dispose of in this filing?

He reported a disposition of 13,602 common shares. The transaction, coded "F", was priced at $82.12 per share on January 30, 2026. This reduced his directly owned National Health Investors common stock from 78,330 shares to 64,728 shares following the reported activity.

How many NHI shares does the CIO own after these Form 4 transactions?

He directly beneficially owns 64,728 NHI common shares after the transactions. Following the option exercises that raised his holdings to 78,330 shares and the 13,602-share disposition, the Form 4 reports a remaining direct ownership balance of 64,728 National Health Investors shares.

What is Kevin C. Pascoe’s role at National Health Investors Inc.?

Kevin C. Pascoe serves as Chief Investment Officer of National Health Investors. The Form 4 identifies him as an officer with the title "Chief Investment Officer," and the reported transactions reflect changes in his directly held common stock position in the company.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

PASCOE KEVIN CARLTON

(Last) (First) (Middle)

222 ROBERT ROSE DRIVE

(Street)

MURFREESBORO TN 37129

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
NATIONAL HEALTH INVESTORS INC [ NHI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Investment Officer

3. Date of Earliest Transaction (Month/Day/Year)
01/30/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/30/2026		M		8,500	A	$54.73	69,830	D
Common Stock	01/30/2026		M		8,500	A	$57.76	78,330	D
Common Stock	01/30/2026		F		13,602	D	$82.12	64,728	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy) 2023	$54.73	01/30/2026		M			8,500	02/24/2025	02/24/2028	Common Stock	8,500	$0	0	D
Stock Option (Right to Buy) 2024	$57.76	01/30/2026		M			8,500	02/23/2025	02/23/2029	Common Stock	8,500	$0	0	D

Explanation of Responses:

	/s/Kevin C. Pascoe	02/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.